New Talk: Forward Engineering Cell Therapy Production Capabilities to Save Patient Lives

John Lee, PhD, Head of Cell Therapy , Center for Breakthrough Medicines

There is a critical shortage in cell therapy manufacturing slots that has resulted in long waitlists for CAR T eligible patients and lengthy vein-to-vein times from apheresis to infusion. This has translated into physicians being forced to make hard choices on which of their patients can get potentially life-saving therapies. Against this backdrop, CDMO’s like Center for Breakthrough Medicines have the chance to alleviate that pain by bringing flexible capacity to market.

In this talk, you will learn: 

– How to forward engineer a facility that enables modularity to accommodate an array of processes and increase efficiency and throughput

– What to consider from new regulatory draft guidance on CAR T CMC, testing and process controls

– Why a close partnership with IT and Digital will push the pedal on innovation with the right automation and monitoring technologies

Watch the full talk below.

In need of immediate assistance with your cell therapy manufacturing? Contact us here or simply call to speak with a CBM expert: 866-274-4009.